(Q39649359)

English

Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma

scientific article published on October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

0 references

author name string

L H L Marchi

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

T Paschoalin

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

L R Travassos

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

E G Rodrigues

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

110-122

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Gamma delta T cells provide an early source of interferon gamma in tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

The IFN gamma receptor: a paradigm for cytokine receptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Impaired interferon signaling is a common immune defect in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Tumor-infiltrating T lymphocytes: friends or foes?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Strategies for use of IL-10 or its antagonists in human disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Melanoma heterogeneity: differential, invasive, metastatic properties and profiles of cathepsin B, D and L activities in subclones of the B16F10-NEX2 cell line.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

A receptor for interleukin 10 is related to interferon receptors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Gene Therapy against Murine Melanoma B16F10-Nex2 Using IL-13Ralpha2-Fc Chimera and Interleukin 12 in Association with a Cyclopalladated Drug

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Characterization of recombinant extracellular domain of human interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Regression in skin tumours: a common phenomenon

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

The regressing thin malignant melanoma: a distinctive lesion with metastatic potential

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Cancer vaccines: between the idea and the reality

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Breaking down the barriers to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Comparison of interleukin-22 and interleukin-10 soluble receptor complexes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Dendritic cells and immunotherapy for malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Cancer immunotherapy by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for activating Th1 response

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

A crucial role for dendritic cell (DC) IL-10 in inhibiting successful DC-based immunotherapy: superior antitumor immunity against hepatocellular carcinoma evoked by DC devoid of IL-10.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

21 January 2018

Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

Metastatic malignant melanoma of unknown primary origin: a study of 30 cases

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced tumor development in mice lacking a functional type I interferon receptor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous elicitation of potent antitumor immunity and eradication of established tumors by administration of DNA encoding soluble transforming growth factor-beta II receptor without active antigen-sensitization

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-6 Production by Pulmonary Dendritic Cells Impedes Th1 Immune Responses

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.58

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2010.58

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39649359&oldid=2203055703"